CAR T-Cell Therapy for Pediatric Leukemia Is Cost-effective CAR T-Cell Therapy for Pediatric Leukemia Is Cost-effective

A new analysis shows that, despite its exorbitant price tag, the CAR T-cell therapy tisagenlecleucel for pediatric leukemia appears to be cost-effective.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news